Craniopharyngioma diagnostic study of choice

Revision as of 17:40, 25 February 2019 by Marjan Khan (talk | contribs)
Jump to navigation Jump to search

Craniopharyngioma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Craniopharyngioma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Treatment

Medical Therapy

Surgery

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Craniopharyngioma diagnostic study of choice On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Craniopharyngioma diagnostic study of choice

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Craniopharyngioma diagnostic study of choice

CDC on Craniopharyngioma diagnostic study of choice

Craniopharyngioma diagnostic study of choice in the news

Blogs on Craniopharyngioma diagnostic study of choice

Directions to Hospitals Treating Craniopharyngioma

Risk calculators and risk factors for Craniopharyngioma diagnostic study of choice

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

The diagnostic evaluation of craniopharyngioma includes high-definition brain imaging. Brain MRI with and without contrast is the gold standard. Computed tomography (CT) scan is optional and may show some calcifications that can be seen in these tumors. However CT is not specific enough as a stand alone diagnostic test. Vascular imaging studies such as MR angiography (MRA) or CTA is decided on a case-by-case basis typically for surgical planning or if a possible vascular malformation is suspected.

Diagnostic Study of Choice

Study of choice

References

  1. Müller HL, Merchant TE, Puget S, Martinez-Barbera JP (May 2017). "New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma". Nat Rev Endocrinol. 13 (5): 299–312. doi:10.1038/nrendo.2016.217. PMID 28155902.
  2. Cohen LE (August 2016). "Update on childhood craniopharyngiomas". Curr Opin Endocrinol Diabetes Obes. 23 (4): 339–44. doi:10.1097/MED.0000000000000264. PMID 27258775.
  3. Martinez-Gutierrez JC, D'Andrea MR, Cahill DP, Santagata S, Barker FG, Brastianos PK (December 2016). "Diagnosis and management of craniopharyngiomas in the era of genomics and targeted therapy". Neurosurg Focus. 41 (6): E2. doi:10.3171/2016.9.FOCUS16325. PMID 27903124.
  4. Patel VS, Thamboo A, Quon J, Nayak JV, Hwang PH, Edwards M, Patel ZM (December 2017). "Outcomes After Endoscopic Endonasal Resection of Craniopharyngiomas in the Pediatric Population". World Neurosurg. 108: 6–14. doi:10.1016/j.wneu.2017.08.058. PMID 28838874.
  5. Müller HL (June 2014). "Craniopharyngioma". Endocr. Rev. 35 (3): 513–43. doi:10.1210/er.2013-1115. PMID 24467716.

Template:WH Template:WS